Imaging characteristics of patients with cardiac sarcoidosis who presented with ventricular arrhythmias

J Cardiol. 2025 Aug;86(2):179-186. doi: 10.1016/j.jjcc.2025.02.004. Epub 2025 Feb 12.

Abstract

Background: Ventricular arrhythmia (VA) is an ominous manifestation of cardiac sarcoidosis (CS). Hence, identifying specific characteristics associated with VA in imaging modalities may enhance risk stratification.

Methods: Fifty-nine patients diagnosed with CS were retrospectively studied and grouped based on presenting symptoms as the VA group (sustained ventricular tachycardia and ventricular fibrillation) and the non-VA group (atrioventricular block, heart failure, and other symptoms). Thirty-nine patients underwent comprehensive evaluation by cardiac magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for comparing cardiac involvement distribution.

Results: The VA group (n = 15) showed higher prevalence of right bundle branch block, basal interventricular thinning, and left ventricle wall motion abnormality. In Cox analysis, VA at baseline (hazard ratio 4.75, p = 0.008) was associated with poor outcomes. The VA group showed a larger extent of late gadolinium enhancement than the non-VA group, especially in the left ventricular mid inferoseptal, right ventricular (RV) basal lateral to mid lateral, and RV apical anterior lesions. FDG-PET accumulation was prominent in the RV basal lateral to basal inferior, and mid anterior lesions in the VA group.

Conclusions: Patients who presented with VA had worse outcomes and a larger cardiac involvement predominant to the RV and ventricular septum; RV predominant scar pattern may serve as a surrogate in patients with CS and explain possible correlation with electrophysiological abnormalities.

Keywords: Cardiac magnetic resonance; Cardiac sarcoidosis; Late gadolinium enhancement; Ventricular arrhythmia.

MeSH terms

  • Adult
  • Aged
  • Arrhythmias, Cardiac* / etiology
  • Cardiomyopathies* / complications
  • Cardiomyopathies* / diagnostic imaging
  • Female
  • Fluorodeoxyglucose F18
  • Heart Ventricles / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging
  • Magnetic Resonance Imaging, Cine
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Retrospective Studies
  • Sarcoidosis* / complications
  • Sarcoidosis* / diagnostic imaging
  • Tachycardia, Ventricular* / diagnostic imaging
  • Tachycardia, Ventricular* / etiology
  • Ventricular Fibrillation* / diagnostic imaging
  • Ventricular Fibrillation* / etiology

Substances

  • Fluorodeoxyglucose F18
  • Radiopharmaceuticals